Tricyclic isoxazolines: identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and alpha2-adrenoceptor antagonism.
暂无分享，去创建一个
M. Bakker | A. Megens | X. Langlois | J. M. Alonso | T. Steckler | W. Drinkenburg | R. Álvarez | J. Pastor | J. Andrés | J. Alcázar | J. Cid | L. Iturrino | Sonia Martínez | A. D. de Lucas | I. Biesmans | I. Lenaerts | S. Pullan | Javier Fernández | L. M. Font | Ana Isabel de Lucas